Shares of this biotech giant have lost 19.2% in the past six months against the industry’s growth of 0.6%. The stock has also ...

Detailed price information for Puretech Health Plc ADR (PRTC-Q) from The Globe and Mail including charting and trades.

Bristol Myers Squibb (BMY) and GSK PLC (GSK) are among the largest global biopharma companies with broad and diverse portfolios. Bristol Myers is focused on discovering, developing and delivering ...

In September 2025, The FDA approved an injectable extended-release risperidone suspension from Amneal Pharmaceuticals, ...

What it also allows us to do is to develop and deploy significant capital into areas where we think there is the potential ...

LB Pharmaceuticals, which has a schizophrenia medicine headed for late-stage testing, broke one of the longest droughts for ...

PGIM shares how the Jennison Health Sciences Fund weathered Q2 volatility by leaning into undervalued innovators. Discover ...

Positive news from a rival sparked a sympathy rally. This was aided by a positive research note published by an analyst. The clinical-stage biotech, closely watched by some because of its ...

Shares of Viking Therapeutics plummeted more than 43% Tuesday after the company revealed poorer-than-expected mid-stage trial data for its experimental weight-loss pill, joining Eli Lilly with similar ...

MT-601 shows a 66% response rate in NHL patients, with 50% achieving a complete response. No dose-limiting toxicities or serious adverse events were reported in the Phase 1 trial. Get the data-driven ...

The safety and tolerability data were at odds with an earlier phase 1 trial, and not as good as a comparable drug trial result from Eli Lilly. Viking may decide to take VK2735 (oral form) through ...